000K  utf8
1100  2024$c2024-09-24
1500  eng
2050  urn:nbn:de:gbv:27-dbt-62738-3
2051  10.3390/ijms251910293
3000  Harutyunyan, Tigran
3010  Aroutiounian, Rouben
3010  Hovhannisyan, Galina
3010  Kalashyan, Lily
3010  Liehr, Thomas
3010  Sargsyan, Anzhela
3010  Stepanyan, Naira
4000  DNA Damage in Moderate and Severe COVID-19 Cases: Relation to Demographic, Clinical, and Laboratory Parameters  [Harutyunyan, Tigran]
4060  17 Seiten
4209  The ability of the SARS-CoV-2 virus to cause DNA damage in infected humans requires its study as a potential indicator of COVID-19 progression. DNA damage was studied in leukocytes of 65 COVID-19 patients stratified by sex, age, and disease severity in relation to demographic, clinical, and laboratory parameters. In a combined group of COVID-19 patients, DNA damage was shown to be elevated compared to controls (12.44% vs. 5.09%, p < 0.05). Severe cases showed higher DNA damage than moderate cases (14.66% vs. 10.65%, p < 0.05), and males displayed more damage than females (13.45% vs. 8.15%, p < 0.05). DNA damage is also correlated with international normalized ratio (INR) (r = 0.471, p < 0.001) and creatinine (r = 0.326, p < 0.05). In addition to DNA damage, severe COVID-19 is associated with age, C-reactive protein (CRP), and creatinine. Receiver operating characteristic analysis identified age, INR, creatinine, DNA damage, and CRP as significant predictors of disease severity, with cut-off values of 72.50 years, 1.46 s, 78.0 µmol/L, 9.72%, and 50.0 mg/L, respectively. The results show that DNA damage correlates with commonly accepted COVID-19 risk factors. These findings underscore the potential of DNA damage as a biomarker for COVID-19 severity, suggesting its inclusion in prognostic assessments to facilitate early intervention and improve patient outcomes.
4950  https://doi.org/10.3390/ijms251910293$xR$3Volltext$534
4950  https://nbn-resolving.org/urn:nbn:de:gbv:27-dbt-62738-3$xR$3Volltext$534
4961  https://www.db-thueringen.de/receive/dbt_mods_00062738
5051  570
5550  comet assay
5550  COVID-19
5550  DNA damage
5550  SARS-CoV-2 virus